Compare CGO & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CGO | SRZN |
|---|---|---|
| Founded | 2004 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 112.9M | 117.8M |
| IPO Year | N/A | N/A |
| Metric | CGO | SRZN |
|---|---|---|
| Price | $11.57 | $19.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $38.50 |
| AVG Volume (30 Days) | 34.7K | ★ 108.1K |
| Earning Date | 01-01-0001 | 11-07-2025 |
| Dividend Yield | ★ 9.25% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,604,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.90 | $5.90 |
| 52 Week High | $10.93 | $24.94 |
| Indicator | CGO | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 57.40 | 46.01 |
| Support Level | $11.38 | $21.03 |
| Resistance Level | $11.63 | $23.42 |
| Average True Range (ATR) | 0.14 | 1.98 |
| MACD | 0.03 | -0.52 |
| Stochastic Oscillator | 90.49 | 1.79 |
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).